Corporate insider profile
Raymond Anderson Insider Trades
Raymond Anderson has reported no open-market purchases on SEC Form 4 and is a net seller of $565,936 across 1 company. The most recent open-market transaction was reported on Nov 2, 2026. Source: SEC Form 4 filings.
Latest reported as Corporate insider of Monopar Therapeutics (MNPR).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$565,935.78
- Latest transaction
- Nov 2, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Raymond Anderson insider trading FAQ
- Is Raymond Anderson buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Raymond Anderson is a net seller of $565,936, with no open-market purchases reported. The latest transaction was reported on Nov 2, 2026.
- Which companies does Raymond Anderson report insider trades for?
- Raymond Anderson has reported open-market trades in Monopar Therapeutics (MNPR). The latest SEC-reported relationship is Corporate insider of Monopar Therapeutics (MNPR).
- Where does Raymond Anderson's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1362489, and refreshes this page daily.
